Biotech & Life SciencesAIHardware & SemiconductorsCybersecurityManufacturingRobotics & AutomationClimate & EnergyHealthcare
IQ Capital is a venture capital firm that focuses on investing in deep tech companies with defensible intellectual property, breakthrough technologies, and global market potential, from seed to growth stages. Their strategy involves active participation, providing capital, guidance, and leveraging their networks and operational experience to help portfolio companies achieve sustainable growth in sectors such as AI, cybersecurity, advanced engineering, and enterprise software.
Deal activity increased 83% year-over-year (11 deals in the last 12 months). Average disclosed round size is $32.9M (across 46 rounds with reported amounts).
Portfolio
46
Fund Size
$1B
Top Stage
Series A
Last 12 Mo
11
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
46 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Tropic | Series C | $105M | Mar 2026 |
 Isembard | Series C | $50M | Mar 2026 |
 VulcanForms | Series D | $220M | Jan 2026 |
 Nu Quantum | Series A | $60M | Dec 2025 |
 Gravis Robotics | Series B | $23M | Nov 2025 |
 Trogenix | Series A | $80M | Oct 2025 |
 AiM Medical Robotics | Series A | $8.1M | Sep 2025 |
 Synthesized | Series A | $17M | Sep 2025 |
 DaltonTx | Seed | $4M | Sep 2025 |
| AAccelerComm | Unknown | $13.1M | Jun 2025 |
 Nyobolt | Series B | $30M | Apr 2025 |
 Alpine Eagle | Seed | $11.0M | Mar 2025 |
 Cambridge GaN Devices | Series C | $30.5M | Feb 2025 |
 IONATE | Series A | $17M | Feb 2025 |
 Molyon | Seed | $4.6M | Nov 2024 |
 Vsim | Seed | $21.5M | Sep 2024 |
| NNanoSyrinx | Unknown | $12.7M | Sep 2024 |
 Wobble Genomics | Unknown | $9.9M | Mar 2024 |
 Mytos | Series A | $19M | Nov 2023 |
 QuantumDiamonds | Seed | $7M | Nov 2023 |
| Nu Quantum | Seed | $8M | Nov 2023 |
| AAi Build | Series A | $8.5M | Oct 2023 |
 Odin | Seed | $3M | May 2023 |
 Congruence Therapeutics | Series A | $65M | Mar 2023 |
 CyberSmart | Series B | $15.4M | Feb 2023 |
Page 1 of 2
Top Co-Investors
Seedcamp6 shared
Mercia3 shared
BGF3 shared
British Patient Capital3 shared
Amadeus Capital Partners2 shared
Presidio Ventures2 shared
Ahren2 shared
HSBC2 shared
ING Ventures2 shared
AlbionVC2 shared
Redalpine2 shared
Eli Lilly and Company2 shared
Cancer Research Horizons2 shared
Seraphim Space1 shared
Deep Tech Labs1 shared
General Catalyst1 shared
HCVC1 shared
Sony Innovation Fund by IGV1 shared
SBI Investment1 shared
Global Brain1 shared
Last updated: 12 April 2026